For women in many parts of the Middle East and Africa, a routine health screening can be a logistical and cultural minefield. Nabta Health, a Sharjah-based startup founded in 2017, is betting that a hybrid model of virtual and in-person care, sold primarily through employers, can change that calculus. Its proposition is not just access, but a shift toward prevention, using AI-driven intake to surface risk factors for conditions like diabetes and hypertension long before they become critical [Clinical Trials Arena, Aug 2023]. The company has raised an estimated $4.5 million to build what it calls a vertically integrated ecosystem for women's health, anchored by a licensed physical clinic in the UAE [VCpedia, Unknown] [Nabta Health, Unknown].
The hybrid wedge
Nabta's model is a three-part assembly. It begins with a licensed physical clinic, which provides a regulatory anchor and a point for necessary in-person procedures. This is supported by a virtual network of general practitioners, nurses, and allied health professionals for remote consultations. The third piece is a mobile-first platform that guides users through goal-based care plans, focusing on upstream metrics like weight management, stress, and energy levels [Clinical Trials Arena, Aug 2023]. The company's AI component analyzes intake data, surfacing age and life-stage-specific risk factors to prompt earlier screening. This integrated approach is designed to fit into a woman's daily life, accessible from home or work, and is primarily sold as a subscription add-on to corporate insurance plans [Nabta Health, Unknown]. The bet is that by catching non-communicable diseases (NCDs) earlier, Nabta can improve outcomes for women while reducing long-term costs for employers.
A focus on the uninsured and under-insured
The company's stated mission is to provide "affordable, accessible, and culturally intelligent care" to a population that is often overlooked: uninsured and under-insured women across the Middle East and Africa [Nabta Health, Unknown]. This focus shapes its product and go-to-market strategy. Rather than pursuing a direct-to-consumer model that might face adoption and payment hurdles, Nabta is targeting the B2B2C pathway through employers and governments. This allows it to bundle its services as a benefit, lowering the individual barrier to entry. The annual subscription includes comprehensive at-home tests, aiming to make preventive screening a habitual part of healthcare [Nabta Health, Unknown]. For employers, the value proposition is framed around detecting health risks earlier, guiding benefit design, and improving workforce outcomes, theoretically reducing avoidable insurance claims [Nabta Health, Unknown].
Funding and leadership
Nabta Health has raised a total of $4.5 million according to multiple sources, though the breakdown of rounds is not fully detailed in the public record [VCpedia, Unknown] [Femtech Insider, Unknown]. A $2 million pre-Series A round was reported in November 2025 [Dharab, November 2025]. An earlier seed round of $1.5 million was led by Basim Anwer of the Regionality Group of Companies [WAYA Media, Unknown]. The company is led by founder and CEO Sophie Smith, who has a background in digital health entrepreneurship in the Gulf region. The leadership team includes Chief Medical Officer Dr. Fadi Mirza, COO Dr. Panna Morgan, Clinic General Manager Cosette Fakih, and non-executive Chairman Iain McMillan [Dharab, Unknown] [Health & Protection, Unknown].
| Role | Name |
|---|---|
| Founder & CEO | Sophie Smith |
| Chief Medical Officer | Dr. Fadi Mirza |
| Chief Operating Officer | Dr. Panna Morgan |
| Clinic General Manager | Cosette Fakih |
| Chairman | Iain McMillan |
The competitive and regulatory landscape
Nabta operates in a region where women's health services can be fragmented and where cultural norms sometimes present barriers to care. Its hybrid model attempts to navigate these complexities by offering privacy and convenience through virtual care, backed by the legitimacy of a physical clinic. The competitive set appears limited in its specific niche, though companies like Ordinary Folk operate in adjacent digital health spaces. Nabta's primary competition may be inertia and the existing, often inefficient, standard of care. The company's regulatory strategy, hinging on a licensed clinic, is a deliberate choice to operate within, rather than around, local healthcare frameworks. This should, in theory, provide a more stable foundation for scaling, though it also introduces the operational complexities of running a physical facility.
What to watch
The next twelve months will test several core assumptions behind Nabta's model. Key milestones will likely involve scaling its employer partnerships and demonstrating tangible outcomes data. The recent pre-Series A funding should fuel this expansion. Observers should look for evidence of renewal and expansion within its initial corporate client base, as well as any moves into adjacent markets or government contracts. The company's ability to generate and publish peer-reviewed data on its AI-driven risk stratification and its impact on early diagnosis rates would significantly bolster its clinical credibility. Furthermore, how the team scales its provider network while maintaining care quality will be a critical operational challenge.
For the patient population Nabta serves,women at risk for or managing non-communicable diseases like type 2 diabetes, cardiovascular conditions, and metabolic syndrome,the standard of care today is often reactive and episodic. It typically involves visiting a general practitioner, perhaps at a public clinic or hospital, when symptoms become pronounced. Preventive screenings are not systematically encouraged or easily accessible, especially for asymptomatic individuals. The result is that diagnoses frequently come later in the disease progression, when management is more complex and costly, and outcomes are worse. Nabta's entire model is predicated on inverting this sequence, making prevention and early detection the default pathway.
Sources
- [Nabta Health, Unknown] Personalised Preventive Care for Women | Nabta Health, https://nabtahealth.com/
- [Clinical Trials Arena, Aug 2023] Women first: the Gulf's new healthcare blueprint, https://www.clinicaltrialsarena.com/features/women-first-the-gulfs-new-healthcare-blueprint/
- [VCpedia, Unknown] Nabta Health - Startup Details - VCpedia, https://vcpedia.com/startups/5120
- [Femtech Insider, Unknown] Nabta Health funding information, Source not provided
- [Dharab, November 2025] Nabta Health closes $2 million pre-Series A, https://www.wamda.com/2025/11/nabta-health-closes-2-million-pre-series-a-expand-hybrid-women-health-model
- [WAYA Media, Unknown] Nabta Health seed round, Source not provided
- [Health & Protection, Unknown] Iain McMillan role at Nabta Health, Source not provided
- [Dharab, Unknown] Nabta Health leadership team, Source not provided